Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 25, 2017

CESAR CASTILLO, INC. v. MYLAN, INC., et al

Track this case

Case Number:

2:17-cv-02813

Court:

New Jersey

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Madeline Cox Arleo

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 17, 2017

    Mylan, Pfizer Escape Suit Over EpiPen Pricing

    An EpiPen direct purchaser's decision to drop a proposed class action, alleging pharmaceutical companies including Mylan Inc. and Pfizer Inc. stifled competition in an effort to drive up prices for their potentially lifesaving allergy treatment, was approved in a New Jersey federal court on Tuesday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login